JAC-Antimicrobial Resistance

JAC Antimicrob Resist

2632-1823

Therapeutic Area

Bacteriology, Biotechnology, Infectious Diseases/ Infectology, Microbiology, Pharmacology, Research, Virology

Academics, Bacteriologists, Biotechnologists, Clinicians, Infectious Disease Specialists, Microbiologists, Pharmacologists, Researchers, Virologists

Aim: JAC-Antimicrobial Resistance (JAC-AMR) publishes clinically oriented opinions, reviews and original articles that advance the science and knowledge of antimicrobial resistance, stewardship and use relating to antibacterial, antifungal, antiviral and antiprotozoal agents. The Journal publishes primarily in human medicine, but articles in veterinary medicine will be considered, provided they fall within the scope of a regional or global ‘one health’ approach to antimicrobials. As part of its commitment to support education with an emphasis on stewardship, JAC-AMR will also provide commentary and peer review on educational resources available online, in the form of a structured review of the content of the resources. Scope JAC-AMR particularly welcomes high-quality, original articles on behaviour change research, clinical trials, education research, epidemiology, health services and observational research, quality improvement science, and narrative or systematic reviews, and meta-analyses that have a clear, contemporaneous message in one or more of the following areas: The practice of evidence-based education, medicine, public health or quality improvement relating to antimicrobial resistance, stewardship and use; Other aspects of antimicrobial resistance, stewardship and use that fulfil the above criteria; The pharmacokinetics/pharmacodynamics, administration and management of antimicrobials, including in the outpatient parenteral antimicrobial therapy (OPAT) and complex outpatient oral and parenteral antimicrobial therapy (COPAT) settings; Other aspects of OPAT and COPAT (as defined above) that fulfil the above criteria ; The clinical use of non-antimicrobial approaches in infection management; The clinical use of novel diagnostics or new diagnostic approaches in infection management; Diagnostic stewardship relating to clinical infection management; Clinical aspects of antimicrobial adverse effects, allergies/intolerances or drug–drug interactions; The shared patient–prescriber decision-making approach to clinical infection management.

British Society for Antimicrobial Chemotherapy (BSAC)

Oxford University Press

Impact Factor JCR Categories/Rank Electronic Circulation Submission to Acceptance Acceptance to Online Publication Frequency Author Submission Guidelines